Comunicati Stampa
Cibi e Bevande

Information on the total number of voting rights and shares

Regulated Information Ghent, BELGIUM – 3 January 2023 , 18:00 CET– Biotalys NV (hereafter the“Company”or“Biotalys ”), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions(Euronext - BTLS), announces the reduction of the share capital in accordance with article 7:210 of the Belgian Code on Companies and Associations, as decided by the Extraordinary Shareholders' Meeting of 27 December 2022, bringing the share...
Ghent, (informazione.news - comunicati stampa - cibi e bevande)

Ghent, BELGIUM – 3 January 202 3 , 18 :00 CET – Biotalys NV (hereafter the “Company” or “Biotalys ”), an Agricultural Technology (AgTech) company protecting crops and food with protein-based biocontrol solutions (Euronext - BTLS), announces the reduction of the share capital in accordance with article 7:210 of the Belgian Code on Companies and Associations, as decided by the Extraordinary Shareholders' Meeting of 27 December 2022, bringing the share capital from EUR 82.204.665,05 to EUR 44,547,917.34 without reduction of the number of shares.

In view hereof, and in accordance with article 15 of the Belgian Act of 2 May 2007 on the disclosure of major shareholdings (the “ Belgian Ac t ”), the outstanding share capital and outstanding voting securities of the Company can be summarised as follows:

Pursuant to the Belgian Act, a notification to the Company and the Belgian Financial Services and Markets Authority (FSMA) is required by all natural and legal persons in each case where the percentage of voting rights attached to the securities held by such persons in the Company reaches, exceeds or falls below the threshold of 5%, 10%, and every subsequent multiple of 5%, of the total number of voting rights in the Company.
For further information, please contact:  
Toon Musschoot, Head Investor Relations & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company protecting crops and food with proprietary protein-based biocontrol solutions and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and is listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

Attachments


Per maggiori informazioni
Sito Web
www.biotalys.com
Ufficio Stampa
 Nasdaq GlobeNewswire (Leggi tutti i comunicati)
2321 Rosecrans Avenue. Suite 2200
90245 El Segundo Stati Uniti
Allegati
Non disponibili